White Paper

Lessons Learned When Implementing A Risk Management Program

By Annette Stemhagen, DrPH, FISPE Senior Vice President and Chief Science Officer, Safety, Epidemiology, Registries, and Risk Management

magnifying glass w pills 450x300

Insights into the type of REMS program which may be required can be found by looking at recently approved REMS or those already in the marketplace. The FDA often relies on precedents when determining REMS requirements. For some products, the FDA has required Shared System REMS; for these, multiple sponsors must operate together under one REMS. UBC has the knowledge gained from designing and implementing multiple REMS across different therapeutic areas and targeting different risks.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: